Cellular Biomedicine Group, Inc. (CBMG) is a publicly traded company in the Unknown sector. Across all available filings, 12 corporate insiders have executed 180 transactions totaling $9.4M, demonstrating a bearish sentiment with -$6.2M in net insider flow. The most recent transaction on Feb 19, 2021 involved a transaction of 476,817 shares valued at $0.
No significant insider buying has been recorded for CBMG in the recent period.
No significant insider selling has been recorded for CBMG in the recent period.
Based on recent SEC filings, insider sentiment for CBMG is bearish with an Insider Alignment Score of 17/100 and a net flow of -$6.2M. Insiders are reducing their positions, though this can be driven by factors unrelated to company outlook.
Insider trading at Cellular Biomedicine Group, Inc. (CBMG) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 12 insiders are actively trading CBMG stock, having executed 180 transactions in the past 90 days. The most active insider is Moon Resources Ltd Full (Executive), who has made 2 transactions totaling $5.0M.
Get notified when executives and directors at CBMG file new Form 4 transactions
Date | Insider | Title | Type | Shares | Price | Value | Flags |
|---|---|---|---|---|---|---|---|
| Feb 19, 2021 | Liu Tony | Executive | Other | 476,817 | $N/A | $0 | |
| Feb 19, 2021 | Liu Tony | Executive | Award | 240,000 | $N/A | $0 | |
| Feb 19, 2021 | Liu Tony | Executive | Disposition | 10,700 | $N/A | $0 | |
| Feb 19, 2021 | K. Chan Andrew | Executive | Award | 48,000 | $N/A | $0 | |
| Feb 19, 2021 | K. Chan Andrew | Executive | Disposition | 239,747 | $N/A | $0 | |
| Feb 19, 2021 | Yao Yihong | Executive | Disposition | 18,900 | $N/A | $0 | |
| Feb 19, 2021 | Yao Yihong | Executive | Award | 54,000 | $N/A | $0 | |
| Feb 19, 2021 | Yao Yihong | Executive | Other | 88,549 | $N/A | $0 | |
| Feb 19, 2021 | Tao Liu Wen | Executive | Disposition | 213,076 | $N/A | $0 | |
| Dec 12, 2019 | K. Chan Andrew | Executive | Award | 20,000 | $N/A | $0 | |
| Oct 28, 2019 | Yao Yihong | Executive | Sale | 193 | $15.08 | $2.9K | |
| Oct 28, 2019 | Liu Tony | Executive | Sale | 875 | $15.08 | $13.2K | |
| Oct 28, 2019 | K. Chan Andrew | Executive | Sale | 485 | $15.08 | $7.3K | |
| Sep 27, 2019 | Yao Yihong | Executive | Sale | 193 | $14.68 | $2.8K | |
| Sep 27, 2019 | Liu Tony | Executive | Sale | 875 | $14.68 | $12.8K |
| TYPE | COUNT | VALUE | % |
|---|---|---|---|
Sale(S) | 103 | $7.8M | 57.8% |
Exercise (Options)(X) | 1 | $3.0M | 22.5% |
Purchase(P) | 15 | $1.6M | 12.0% |
Exercise(M) | 22 | $860.9K | 6.4% |
Award(A) | 9 | $150.0K | 1.1% |
Payment(F) | 9 | $27.2K | 0.2% |
Other(J) | 11 | $0 | 0.0% |
Disposition(D) | 4 | $0 | 0.0% |
Gift(G) | 6 | $0 | 0.0% |
Insider selling pressure at Cellular Biomedicine Group, Inc. has increased, with 12 insiders executing 180 transactions across all time. Total sales of $7.8M significantly outpace purchases of $1.6M, resulting in a net outflow of $6.2M. This selling activity appears largely discretionary, which may warrant closer attention from investors.